In the late 1960s, scientists discovered a miracle drug for Parkinson’s disease — a simple, inexpensive dopamine-replacement ...

Parkinson’s disease (PD) is the fastest-growing neurological disorder globally, affecting nearly one million people in the ...

Research shows life expectancy growth is slowing, with significant implications for health policies and individual planning ...

Introduction Although there are some drugs to control Parkinson’s disease (PD), they have several side effects and cannot ...

Regular exercise significantly boosts brain health by increasing blood flow and a key protein, BDNF, which aids in learning, ...

This article originally published at After her son's painful death, a Cheshire mother highlights Connecticut's pediatric hospice gap.

Researchers in Japan recruited more than 1,000 adults over the age of 65 and had them perform dexterity tests with both their ...

As previously communicated, PharmaTher estimates a U.S. treated market opportunity of approximately US$0.75-$2.2 billion for an effective LID-PD therapy, informed by PD prevalence, LID incidence among ...

François L'Italien is coordinator of the Observatoire de la retraite and deputy director of the Institut de recherche en économie contemporaine (IREC). Funding for the Observatoire de la retraite and ...

Humans are living 20 years longer than they were in 1950, according to new research with all 204 countries and territories studied reporting declines in their mortality rates since then. But vast ...

Global life expectancy returned in 2023 to levels seen before the Covid-19 pandemic, rising to 76.3 years for women and 71.5 years for men, according to Global Burden of Disease, a long-running study ...

Money can't buy happiness or love – but it may buy more years of life, a new national report suggests. Older adults in the poorest 20% of the U.S. population die, on average, nine years earlier than ...